Strides Pharma Science Limited is a global pharmaceutical company headquartered in Bangalore, India. The company focuses on research and development, manufacturing, and marketing of a wide range of pharmaceutical products including branded generics, specialty pharma, over-the-counter (OTC) products, and nutraceuticals.

With a presence in over 100 countries and a network of more than 75 partners across the globe, Strides Pharma has established itself as a leading player in the industry. The company's product portfolio covers various therapeutic segments such as antiretrovirals, central nervous system (CNS), cardiovascular, anti-diabetics, oncology, and more.

One of the key factors that sets Strides Pharma apart from its competitors is its focus on innovation and technology. The company has invested significantly in developing novel drug delivery systems to enhance patient compliance and outcomes. Additionally, it has been actively involved in developing complex generic products through technological advancements.

In recent years, Strides Pharma has also made strategic collaborations with multinational companies to expand its product offerings. These partnerships have not only strengthened its market presence but have also facilitated access to new technologies and markets.

The company's commitment to quality and affordability has earned it recognition globally. Its state-of-the-art manufacturing facilities comply with stringent regulatory standards including USFDA approvals for several plants which further demonstrates its dedication to producing high-quality pharmaceuticals.